Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer

Haruhito Azuma, Takeshi Sakamoto, Satoshi Kiyama, Takanobu Ubai, Yatsugu Kotake, Teruo Inamoto, Kiyoshi Takahara, Yasuichiro Nishimura, Naoki Segawa, Yoji Katsuoka

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences